BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25245607)

  • 1. Clinical implications of the hyperdynamic syndrome in cirrhosis.
    Licata A; Mazzola A; Ingrassia D; Calvaruso V; Cammà C; Craxì A
    Eur J Intern Med; 2014 Nov; 25(9):795-802. PubMed ID: 25245607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications of cirrhosis. A 50 years flashback.
    Møller S; Bendtsen F
    Scand J Gastroenterol; 2015 Jun; 50(6):763-80. PubMed ID: 25881709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and treatment of esophageal varices in the cirrhotic patient.
    Ashkenazi E; Kovalev Y; Zuckerman E
    Isr Med Assoc J; 2013 Feb; 15(2):109-15. PubMed ID: 23516775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research on some hemodynamic changes in the cirrhosis of the liver.
    Ciplea A; Zamfirescu NR; Felberg B; Balta N; Drăgulescu N; Turleanu R
    Rev Roum Physiol; 1969; 6(1):25-31. PubMed ID: 5403632
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology and therapeutic options for cirrhotic portal hypertension.
    Guixé-Muntet S; Quesada-Vázquez S; Gracia-Sancho J
    Lancet Gastroenterol Hepatol; 2024 Jul; 9(7):646-663. PubMed ID: 38642564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.
    Bolognesi M; Di Pascoli M; Verardo A; Gatta A
    World J Gastroenterol; 2014 Mar; 20(10):2555-63. PubMed ID: 24627591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis.
    Alvarado-Tapias E; Ardevol A; Garcia-Guix M; Montañés R; Pavel O; Cuyas B; Graupera I; Brujats A; Vilades D; Colomo A; Poca M; Torras X; Guarner C; Concepción M; Aracil C; Torres F; Villanueva C
    J Hepatol; 2020 Oct; 73(4):829-841. PubMed ID: 32298768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
    Gatta A; Bolognesi M; Merkel C
    Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics.
    Kumar A; Mishra SR; Sharma P; Sharma BC; Sarin SK
    J Clin Gastroenterol; 2010 Apr; 44(4):294-300. PubMed ID: 19730114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphologic and functional abnormalities of the cardiovascular system in patients with hepatic cirrhosis].
    Piscione F; Manganiello V; Viola O; Chiariello M
    Ital Heart J Suppl; 2003 Feb; 4(2):85-95. PubMed ID: 12762257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome.
    Blei AT; Mazhar S; Davidson CJ; Flamm SL; Abecassis M; Gheorghiade M
    J Clin Gastroenterol; 2007; 41 Suppl 3():S323-9. PubMed ID: 17975484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Circulatory System in Liver Disease.
    Hollenberg SM; Waldman B
    Crit Care Clin; 2016 Jul; 32(3):331-42. PubMed ID: 27339674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatocardiac disorders : Interactions between two organ systems].
    Horvatits T; Drolz A; Rutter K; Roedl K; Kluge S; Fuhrmann V
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):447-52. PubMed ID: 26070920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelation between esophageal varices, and systemic and hepatic hemodynamics in male patients with compensated cirrhosis.
    Kobayashi A; Katsuta Y; Aramaki T; Okumura H
    Jpn J Med; 1991; 30(4):318-25. PubMed ID: 1942642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond Varices: Complications of Cirrhotic Portal Hypertension in Pediatrics.
    Banc-Husu AM; Shiau H; Dike P; Shneider BL
    Semin Liver Dis; 2023 Feb; 43(1):100-116. PubMed ID: 36572031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
    Møller S; Bendtsen F
    Liver Int; 2018 Apr; 38(4):570-580. PubMed ID: 28921803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic derangement and cardiac dysfunction in cirrhosis.
    Gentilini P; La Villa G; Laffi G; Pinzani M
    Ann Ital Med Int; 2004; 19(2):90-7. PubMed ID: 15317269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.
    Møller S; Henriksen JH; Bendtsen F
    World J Gastroenterol; 2014 Nov; 20(42):15499-517. PubMed ID: 25400435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosis.
    Meng HC; Lin HC; Tsai YT; Lee FY; Liao DM; Hsia HC; Lin WJ; Chang TT; Lay CS; Wang SS
    J Gastroenterol Hepatol; 1994; 9(2):148-53. PubMed ID: 8003648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis.
    Busk TM; Bendtsen F; Møller S
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):523-30. PubMed ID: 23325273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.